Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02184130
Other study ID # tms_percept_zurich
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date October 2011
Est. completion date September 2017

Study information

Verified date June 2018
Source University of Zurich
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The long-term goal of this research is to advance our knowledge of how information from the labyrinth is brought to perception and how adaptation to vestibular imbalance influences motion sensation. Patients with vestibular disorders frequently have disabling disturbances of perception. Related to these symptoms is that large areas of the cerebral hemispheres and the cerebellum receive information from the vestibular, visual and somatosensory systems that is integrated within a vestibular cortical network into an accurate perception of spatial orientation. Interrupting the pathways that process information about the direction of gravity and angular velocity leads to impairment of the internal estimate of gravity and the perception of body motion. The strategy of this research is to use repetitive transcranial magnetic stimulation (rTMS) to produce transient focal lesions that allow study of acute loss of function within the central vestibular pathways at the very beginning of adaptation. Our underlying hypothesis is that the immediate effects of a lesion in the cerebellum will be to affect ocular motor control of vestibular reflexes and perception alike but with a cortical lesion there will be dissociation between ocular motor control and perception. This research helps to understand the mechanisms involved in the perception of vestibular information and the cerebellar influence on processing vestibular input and offers a unique opportunity to make major inroads into the understanding and eventually treatment of the often incapacitating symptoms of patients with vestibular disease


Recruitment information / eligibility

Status Terminated
Enrollment 7
Est. completion date September 2017
Est. primary completion date November 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

1. ages 18-70

2. informed consent

Exclusion Criteria:

1. disturbed consciousness

2. other neurological or systemic disorder which can cause dementia or cognitive dysfunction

3. prior history of a major psychiatric disorder

4. history of definite stroke

5. focal lesion on MRI exam

6. use of anxiolytic, antidepressant, neuroleptic or sedative medication

7. has MRI contraindication such as pacemaker, implanted pumps, shrapnel, etc. (full MRI screening form will be filled out).

8. History of seizure or a family history of epilepsy;

9. increased intracranial pressure, such as after infarctions or trauma

10. pregnancy or possibility of being pregnant unless precluded by a negative pregnancy test

11. history of any significant head trauma.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
transcranial magnetic stimulation and motion stimuli


Locations

Country Name City State
Switzerland University Hospital Zurich, Division of Neurology Zurich ZH

Sponsors (1)

Lead Sponsor Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary changes in verticality perception and self-motion perception after TMS (transcranial magnetic stimulation) within 30min after TMS
Secondary vestibulo-ocular reflex after TMS (transcranial magnetic stimulation) within 30min after TMS